Live Breaking News & Updates on Clinical Access Program
Stay updated with breaking news from Clinical access program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Effectiveness of BPaL regimen for highly drug-resistant TB brings new hope for India biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Makhosandile Zulu Nelisiwe Ngcobo was part of a study of the BPaL regimen treatment after enduring a very, very difficult treatment course. A scientist in 2018 in France studies tuberculosis, a multidrug-resistant form of which could require a shorter treatment plan than previously, according to a 2019 study in a US journal. Picture: AFP/File/Anne-Christine Poujoulat A clinical programme will enrol 400 people in South Africa for treatment with a three-drug, six-month, all-oral regimen of bedaquiline, pretomanid and linezolid, known as the BPaL regimen, that has been shown to demonstrate a favourable outcome in 90% of patients of highly drug-resistant forms of TB. ....
South Africa: Patients in South Africa to Access Six-Month, All-Oral Treatment for Highly Drug-Resistant Tuberculosis allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.